What is the next big thing for your company's portfolio?

To help pharmaceutical companies answer this question, Kaiser Associates conducted a comprehensive analysis of nearly every pharma R&D program in the world and compiled the findings into the Hot Indications List.

Our report includes:2015 Hot Indications List

  • Kaiser's ranking and analysis of the Top 50 indications
  • 4 Therapeutic Area Deep Dives
    • Oncology
    • Neurology
    • Ophthalmology
    • Gastroenterology
  • Top 10 Emerging Orphan Diseases


Complete the form to the right to download your free whitepaper now!